| Title |
Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic
|
|---|---|
| Published in |
JAMA Oncology, October 2020
|
| DOI | 10.1001/jamaoncol.2020.3545 |
| Pubmed ID | |
| Authors |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
An error occurred while generating this chart. Please try again later.
No score history available for this output yet. Please try again later.
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 39% |
| United Kingdom | 5 | 18% |
| Italy | 1 | 4% |
| Chile | 1 | 4% |
| France | 1 | 4% |
| Peru | 1 | 4% |
| Mexico | 1 | 4% |
| Saudi Arabia | 1 | 4% |
| Unknown | 6 | 21% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 68% |
| Scientists | 6 | 21% |
| Practitioners (doctors, other healthcare professionals) | 3 | 11% |
Mendeley demographics
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 16% |
| Other | 6 | 11% |
| Student > Ph. D. Student | 6 | 11% |
| Researcher | 6 | 11% |
| Student > Doctoral Student | 4 | 7% |
| Other | 7 | 12% |
| Unknown | 19 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 30% |
| Biochemistry, Genetics and Molecular Biology | 4 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Nursing and Health Professions | 3 | 5% |
| Agricultural and Biological Sciences | 2 | 4% |
| Other | 6 | 11% |
| Unknown | 22 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 155. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2025.
All research outputs
#319,708
of 32,609,759 outputs
Outputs from JAMA Oncology
#489
of 3,875 outputs
Outputs of similar age
#7,502
of 457,118 outputs
Outputs of similar age from JAMA Oncology
#8
of 98 outputs
Altmetric has tracked 32,609,759 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,875 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 82.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.